Uses in life-threatening cytomegalovirus infections in immunocompromised patients Dosage:5 mg/kg./12 hours for 2:3 weeks . & for 2 weeks as prophylactic.
Capsule
1932 EGP
Uses in life-threatening cytomegalovirus infections in immunocompromised patients Dosage:5 mg/kg./12 hours for 2:3 weeks . & for 2 weeks as prophylactic.
Note: All the provided information about this drug does not substitute for consulting a doctor.